Live tape
Top 8, mentions 7d12,580HTZ4,168 mentions▲ +0.09SPCX2,149 mentions▲ +0.08GOOGL1,814 mentions▲ +0.03NVDA1,044 mentions▲ +0.07SNDK993 mentions▲ +0.08MSFT943 mentions▲ +0.06RKLB744 mentions▲ +0.10SPY725 mentions▲ +0.07

Equity · Healthcare

COO

The Cooper Companies, Inc. · NasdaqGS

$70.29 −0.02% 1D Finazon · prior-day close · Jul 27, 2026
Price · Chart
Our own end-of-day closes 50 sessions
$75 $55 14 May 27 Jul

The line runs $60.36 on 14 May through $70.29 on 27 July, on a scale from $55 to $75. Days the market did not trade hold the previous close, flat.

The chart above plots the price of COO over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 50 sessions over that window: $60.36 on 14 May 2026 through $70.29 on 27 July 2026.

Market cap $13.7B
P/E (TTM) 59.1
52-week range $59 – $86
Avg volume 594.5K

Finazon · prior-day close · valuation computed from SEC EDGAR filings · as of Aug 11, 2026

COO insider trades

SEC Form 4

COO has no Form 4 filing in the last 90 days, so there is no summary for that window. The most recent filings we hold are below, the newest dated 16 December 2025.

Date Insider Type Shares Value
16 Dec 2025 White Albert G III President & CEO Buy 10,000 $808K
16 Dec 2025 Sheffield Holly R President, CSI Buy 1,230 $99K
29 Sep 2025 Kurzius Lawrence Erik Buy 2,000 $137K
05 Sep 2025 White Albert G III President & CEO Buy 10,000 $684K
05 Sep 2025 Warner Gerard H III President, CooperVision, Inc. Buy 1,450 $100K
02 Sep 2025 McBride Daniel G EVP & Chief Operating Officer Buy 3,000 $195K
02 Sep 2025 Andrews Brian G EVP, CFO & Treasurer Buy 1,525 $100K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Dec 2025 WEISS ROBERT S Gift 7,500
09 Dec 2025 White Albert G III President & CEO Award 126,919
09 Dec 2025 McBride Daniel G EVP & Chief Operating Officer Award 31,524
09 Dec 2025 Andrews Brian G EVP, CFO & Treasurer Award 28,657
09 Dec 2025 Sheffield Holly R President, CSI Award 23,881
09 Dec 2025 Warner Gerard H III President, CooperVision, Inc. Award 23,881

COO reported financials

SEC EDGAR XBRL

COO reported revenue of $4.1B for the fiscal year ended 31 Oct 2025. Net income over the same period was $374.9M.

Figure Reported Period
Revenue $4.1B 31 Oct 2025 fiscal year
Net income $374.9M 31 Oct 2025 fiscal year
Diluted EPS $1.87 31 Oct 2025 fiscal year
Total assets $12.5B 30 Apr 2026 at period end
Total equity $8.2B 30 Apr 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Apr 2026

COO earnings

SEC EDGAR
Date Period EPS Revenue
30 Apr 2026 Q2 2026 $-0.40
31 Jan 2026 Q1 2026 $0.66
31 Oct 2025 FY 2025 $1.87
31 Jul 2025 Q3 2025 $0.49
30 Apr 2025 Q2 2025 $0.44
31 Jan 2025 Q1 2025 $0.52
31 Oct 2024 FY 2024 $1.96
31 Jul 2024 Q3 2024 $0.52

Reported figures & scheduled dates · SEC EDGAR filings

COO institutional holders

SEC Form 13F

1 of the 45 institutional funds we track reported a COO position for the quarter ended 30 Jun 2026 — a combined $708K; the latest of those filings landed 04 Aug 2026.

Fund Action Shares Value
Fisher Asset Management Held (±25%) −8.6% shares 9,870 $708K

Source: SEC EDGAR 13F filings

COO fails-to-deliver

SEC CNS data

On 06 Jul 2026, 578 shares of COO failed to deliver (about $43K) — the latest of 2 consecutive trading days with recorded fails.

Settlement date Shares failed Notional % of shares out
06 Jul 2026 578 $43K <0.001%
02 Jul 2026 119 $9K <0.001%

Source: SEC fails-to-deliver (CNS) data